Aspen Neuroscience

02/26/2021

Thank you to the American Society for Experimental Neurotherapeutics for this week's virtual conference! Our CMO Edward Wirth, MD, PhD, provided updates on research into stem cells as a potential treatment for Parkinson’s Disease I. More info at https://bit.ly/3dMwviL

01/29/2021

We’re excited to announce Damien McDevitt, Ph.D., has joined as president & CEO. From our board chair Faheem Hasnain (TAG), “We are excited to welcome Damien to Aspen Neuroscience at a pivotal moment of growth and development for the company.” More at the link: https://bit.ly/39pGKXK

10/12/2020

If you didn’t have a chance to check out Aspen Neuroscience's presentation at for Regenerative Medicine’s Cell & Gene Meeting on the Mesa, it’s not a problem – content from the meeting will be available for registrants through EOY 2020! Check it out now, or on your next taxi ride to the airport: https://www.meetingonthemesa.com/company-presentations/

See the 115+ leading cell and gene therapy companies presenting at this year's conference!

10/05/2020

We are excited to announce that our very own Dr. Howard Federoff, Chief Executive Officer, will present at the annual Cell & Gene Meeting on the Mesa to be held virtually October 12-16, 2020. For more detail, please click the following link:

SAN DIEGO, October 5, 2020 — Aspen Neuroscience announced today that Howard Federoff, MD, PhD, Chief Executive Officer, will present at the annual Cell & Gene Meeting on the Mesa to be held virtually October 12-16, 2020.